Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. Petros Pharmaceuticals Inc’s current trading price is -94.34% away from its 52-week high, while its distance from the 52-week low is 58.67%. The stock’s price range during this period has varied between $0.05 and $1.52. The company, active in the Healthcare sector, saw a trading volume of around 18.89 million for the day, considerably lower average daily volume of 35.0 million observed over the last three months.
The market performance of Petros Pharmaceuticals Inc has been somewhat unstable. Over the past year, the company’s stock achieved a high of $1.52 on 04/01/24, with the lowest value for the same timeframe being $0.05, recorded on 03/25/25.
How Financial Performance Impacts Market Capitalization
Petros Pharmaceuticals Inc (PTPI) has experienced a quarterly decline of -70.15% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 2.57M and boasts a workforce of 21 employees.
The Role of Moving Averages and Trading Volume in Technical Analysis
Based on Barchart.com data, the company’s moving average over the 100-day period was 0.2501, with a change in price of -0.2840. Similarly, Petros Pharmaceuticals Inc recorded 22,139,127 in trading volume during the last 100 days, posting a change of -76.76%.
How PTPI’s Debt-to-Equity Ratio Affects Financial Health
A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for PTPI stands at 2.32. Similarly, the long-term debt-to-equity ratio is also 1.58.
PTPI Stock Stochastic Average
As of today, the raw stochastic average of Petros Pharmaceuticals Inc over the last 50 days is at 5.34%. This shows a declinee from the raw stochastic average of the previous 20 days, which was recorded at 18.09%. Further, the company’s Stochastic %K and %D values for the last 20 days were 32.12% and 27.05%, respectively.
PTPI Stock Price Performance Analysis
Investors’ outlook regarding the stock price performance over the year has been split, with some feeling optimistic and others feeling pessimistic, as it’s been a mixed bag. Year to date metric has recorded a loss of -78.17%.However, over the last six months, we can see a stronger performance of -74.03%. Over the last 30 days, the price of PTPI has leaped by -16.34%. And in the last five days, it has surged by 17.81%.
